Home
About
Portfolio
News
Calendar
Contact
Apply to Present
Member Dashboard

Band of Angels

Home
About
Portfolio
News
Calendar
Contact
Apply to Present
Member Dashboard
Band HQ
March 23, 2020

Portfolio News: US FDA grants EUA for Cepheid’s SARS-CoV-2 test

Band HQ
March 23, 2020
md2-13.jpg

Cepheid has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its rapid molecular diagnostic test, Xpert Xpress SARS-CoV-2. The test is designed for the qualitative detection of SARS-CoV-2 virus, which causes coronavirus (Covid-19) disease.

Read the news article

Newer PostUNest Portfolio News: Nevertheless She Persisted: How A Female Fintech Founder Raised Her Seed Round
Older PostPortfolio News: ClinCapture, Inc. is Providing Free Electronic Data Capture (EDC) for Clinical Researchers Investigating the Treatment of COVID-19 Coronavirus
Back to Top
Band of Angels, LLCBandHQ@bandangels.com

PROUD MEMBER OF THE ANGEL CAPITAL ASSOCIATION

© 2025 Band of Angels, LLC